Monday, 15 May 2017

Protein Therapeutics Market Overview, Growth and Report to 2021

Protein Therapeutics Market
Therapeutic proteins are used to effectively treat a wide array of diseases such as protein deficiency diseases; chronic diseases such as cancer, rheumatoid arthritis (RA), ankylosing spondylitis, diabetes; infections such as human immunodeficiency virus (HIV), hepatitis A, hepatitis B, and hepatitis C; and other medical conditions such as genetic disorders, anemia cases related to kidney dialysis, and cancer-related anemia.

Therapeutic proteins mostly consist of recombinant forms of naturally occurring proteins. The report analysts forecast the global protein therapeutics market to grow at a CAGR of 7.86% during the period 2017-2021.

Covered in this report:

The report covers the present scenario and the growth prospects of the global protein therapeutics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of branded and biosimilar drugs used for the treatment of various diseases.

The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
Protein Therapeutics Market has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendorsoperating in this market.

Key vendors
  • AbbVie
  • Amgen
  • F. Hoffmann-La Roche
  • Johnson & Johnson
  • Merck
  • Novo Nordisk
Other prominent vendors
  • Anhui Anke Biotechnology (Group)
  • AstraZeneca
  • Baxter International
  • Biocon
  • Biodel
  • BioGenomics
  • Biopartners
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Celltrion
  • Chugai Pharmaceutical
  • Diamyd Medical
  • Diasome Pharmaceuticals
  • DiaVacs
  • Dynavax Technologies
  • Eli Lilly
  • Ferring Pharmaceuticals
  • Generex Biotechnology
  • GeneScience Pharmaceuticals
  • Hualan Biological Engineering
  • Intas Pharmaceuticals
  • Ipsen
  • JCR Pharmaceuticals
  • Kyowa Hakko Kirin
  • Lexicon Pharmaceuticals
  • LG Life Sciences
  • MacroGenics
  • MannKind
  • Oramed Pharmaceuticals
  • Osiris Therapeutics
  • Pfizer
  • Sandoz International 
  • Sanofi
  • Teva Pharmaceutical Industries
  • Thermalin Diabetes
  • Tolerion
  • Wockhardt
  • XOMA
Market driver
  • Increased demand for mAbs
  • For a full, detailed list, view our report
Market challenge
  • Complexities in manufacturing, storage conditions, distribution policies, and high cost
  • For a full, detailed list, view our report
Market trend
  • Emergence of next-generation biologics
  • For a full, detailed list, view our report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends ?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendorsin this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

No comments:

Post a Comment